DR Congo receives 70,000 Ebola vaccine doses for outbreak response

by

in

WHO experts say early evidence, including animal studies, suggests Ervebo could offer some protection—and the new trial will seek to establish whether that protection extends to humans.

Leave a Reply

Your email address will not be published. Required fields are marked *